Daniel Ojeda-Juárez

Dr. Daniel Ojeda-Juárez

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
PDF file
SGStephanie Guardado
Stephanie Guardado
DODaniel Ojeda-Juárez
Daniel Ojeda-Juárez
MKMarcus Kaul
Marcus Kaul
TNTara Nordgren
Tara Nordgren
Lipocalin-2 (LCN2) is an inflammatory mediator best known for its role as an innate acute-phase protein. LCN2 mediates the innate immune response to pathogens by sequestering iron, thereby inhibiting pathogen growth. Although LCN2 and its bacteriostatic properties are well studied, other LCN2 functions in the immune response to inflammatory stimuli are less well understood, such as its role as a chemoattractant and involvement in the regulation of cell migration and apoptosis. In the lungs, most studies thus far investigating the role of LCN2 in the immune response have looked at pathogenic inflammatory stimuli. Here, we compile data that explore the role of LCN2 in the immune response to various inflammatory stimuli in an effort to differentiate between protective versus detrimental roles of LCN2.

4 April 2025 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JLJoie Lin
Joie Lin
JCJulia A. Callender
Julia A. Callender
JMJoshua E. Mayfield
Joshua E. Mayfield
DMDaniel B. McClatchy
Daniel B. McClatchy
DODaniel Ojeda-Juárez
Daniel Ojeda-Juárez
CSChristina J. Sigurdson
Christina J. Sigurdson
Neuronal hyperexcitability precedes synapse loss in certain neurodegenerative diseases, yet the synaptic membrane interactions and downstream signaling events remain unclear. The disordered amino terminus of the prion protein (PrP C ) has been implicated in aberrant signaling in prion and Alzheimer’s disease. To disrupt neuronal interactions and signaling linked to the amino terminus, we CRISPR-engineered a knockin mouse expressing mutant PrP C (G92N), generating an N -linked glycosylation site between 2 functional motifs. Mice developed seizures and necrosis of hippocampal pyramidal neurons, similar to prion-infected mice and consistent with excitotoxicity. Phosphoproteomics analysis revealed phosphorylated glutamate receptors and calcium-sensitive kinases, including protein kinase C (PKC). Additionally, 92N-PrP C -expressing neurons showed persistent calcium influx as well as dendritic beading, which was rescued by an N -methyl-d-aspartate receptor (NMDAR) antagonist. Finally, survival of Prnp 92N mice was prolonged by blocking active NMDAR channels. We propose that dysregulated PrP C -NMDAR–induced signaling can trigger an excitatory-inhibitory imbalance, spongiform degeneration, and neurotoxicity and that calcium dysregulation is central to PrP C -linked neurodegeneration.

27 February 2024 in Brain, Behavior, and Immunity
Verified
Journal Article
Open access
NYNina Y Yuan
Nina Y Yuan
KMKathryn E. Medders
Kathryn E. Medders
ASAna Sanchez
Ana Sanchez
RSRohan Shah
Rohan Shah
CRCyrus M. de Rozieres
Cyrus M. de Rozieres
MKMarcus Kaul
Marcus Kaul
Macrophages (MO) infected with human immunodeficiency virus (HIV) -1 or activated by its envelope protein gp120 exert neurotoxicity. We found previously that signaling via p38 mitogen-activated protein kinase (p38 MAPK) is essential to the neurotoxicity of HIVgp120-stimulated MO. However, the associated downstream pathways remained elusive. Here we show that cysteinyl-leukotrienes (CysLT) released by HIV -infected or HIVgp120 stimulated MO downstream of p38 MAPK critically contribute to neurotoxicity. SiRNA-mediated or pharmacological inhibition of p38 MAPK deprives MO of CysLT synthase (LTC4S) and, pharmacological inhibition of the cysteinyl-leukotriene receptor 1 (CYSLTR1) protects cerebrocortical neurons against toxicity of both gp120-stimulated and HIV -infected MO. Components of the CysLT pathway are differentially regulated in brains of HIV -infected individuals and a transgenic mouse model of NeuroHIV (HIVgp120tg). Moreover, genetic ablation of LTC4S or CysLTR1 prevents neuronal damage and impairment of spatial memory in HIVgp120tg mice. Altogether, our findings suggest a novel critical role for cysteinyl-leukotrienes in HIV -associated brain injury.

5 April 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
DODaniel Ojeda-Juárez
Daniel Ojeda-Juárez
GFGail Funk
Gail Funk
EREmily Richards
Emily Richards
ARAlexander J. Rajic
Alexander J. Rajic
DMDaniel B. McClatchy
Daniel B. McClatchy
CSChristina J. Sigurdson
Christina J. Sigurdson
Synaptic dysfunction and loss correlate with cognitive decline in neurodegenerative diseases, including Alzheimer’s disease (AD) and prion disease. Neuronal hyperexcitability occurs in the early stages of AD and experimental prion disease, prior to the onset of dementia, yet the underlying drivers are unclear. Here we identify an increase in the immediate early gene, Arc/Arg3.1, in the human prion disease-affected frontal cortex, suggestive of neuronal hyperactivity. To investigate early signaling events initiated by prion aggregates (PrP Sc ) in human neurons, we stimulated PrP C in human iPSC-derived excitatory neurons (iNs) with a known PrP Sc -mimetic antibody (POM1), which recapitulated the Arc/Arg3.1 response within two hours. Proteomics, RNAseq, and a phosphokinase array in iNs revealed alterations in the EGF receptor and increased phosphorylated phospholipase C (PLC)-γ1 (Y783), which was also observed in the cerebral cortex of prion-infected mice. Thus, PrP C ligands can induce a PLC-γ1 intracellular signaling cascade together with an Arc response, suggestive of a neuronal activity response.

28 February 2025 in Viruses
Verified
Journal Article
Open access
PDF file
IHIndira Harahap-Carrillo
Indira Harahap-Carrillo
DFDominic Fok
Dominic Fok
FWFrances Wong
Frances Wong
GMGabriel Malik
Gabriel Malik
RMRicky Maung
Ricky Maung
MKMarcus Kaul
Marcus Kaul
Methamphetamine (METH) use is frequent among people with HIV (PWH) and appears to increase the risk of neuronal injury and neurocognitive impairment (NCI). This study explored in vivo the effects of a 12 week (long-term), low-dose METH regimen in a transgenic animal model of neuroHIV with inducible expression of HIV-1 transactivator of transcription (Tat). Seven months after transient Tat induction and five months after METH exposure ended, we detected behavioral changes in the Barnes maze (BM) spatial memory task in the Tat and METH groups but not the combined Tat + METH group. The novel object recognition (NOR) task revealed that Tat extinguished discrimination in female animals with and without METH, although METH alone slightly improved NOR. In contrast, in males, Tat, METH, and Tat + METH all compromised NOR. Neuropathological examination detected sex-dependent and brain region-specific changes of pre-synaptic terminals, neurites, and activation of astrocytes and microglia. RNA-sequencing and quantitative reverse transcription polymerase chain reaction indicated that METH and Tat significantly altered gene expression, including factors linked to Alzheimer’s disease-like NCI. In summary, chronic low-dose METH exerts long-term effects on behavioral function, neuropathology, and mRNA expression, and modulates the effects of Tat, suggesting sex-dependent and -independent mechanisms may converge in HIV brain injury and NCI.

1 January 2022
Verified
Book Chapter
Closed access
PDF file
DODaniel Ojeda-Juárez
Daniel Ojeda-Juárez
IHIndira S. Harahap-Carrillo
Indira S. Harahap-Carrillo
MKMarcus Kaul
Marcus Kaul